Versporten A, Sharland M, Bielicki J, Drapier N, Vankerckhoven V, Goossens H. The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J. 2013;32(6):e242–53.
Article
PubMed
Google Scholar
Lass J, Kaar R, Jogi K, Varendi H, Metsvaht T, Lutsar I. Drug utilisation pattern and off-label use of medicines in Estonian neonatal units. Eur J Clin Pharmacol. 2011;67(12):1263-71.
Neubert A, Lukas K, Leis T, Dormann H, Brune K, Rascher W. Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis. Eur J Clin Pharmacol. 2010;66(1):87–95.
Article
PubMed
Google Scholar
Porta A, Esposito S, Menson E, Spyridis N, Tsolia M, Sharland M, et al. Off-label antibiotic use in children in three European countries. Eur J Clin Pharmacol. 2010;66(9):919–27.
Article
PubMed
Google Scholar
Conroy S, McIntyre J. The use of unlicensed and off-label medicines in the neonate. Semin Fetal Neonatal Med. 2005;10(2):115–22.
Article
PubMed
Google Scholar
Kadambari S, Heath PT, Sharland M, Lewis S, Nichols A, Turner MA. Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units. J Antimicrob Chemother. 2011;66(11):2647–50.
Article
CAS
PubMed
Google Scholar
de Hoog M, Mouton JW, van den Anker JN. Vancomycin: pharmacokinetics and administration regimens in neonates. Clin Pharmacokinet. 2004;43(7):417–40.
Article
CAS
PubMed
Google Scholar
Pandolfini C, Kaguelidou F, Sequi M, Jacqz-Aigrain E, Choonara I, Turner MA, et al. Wide intra- and inter-country variability in drug use and dosage in very-low-birth-weight newborns with severe infections. Eur J Clin Pharmacol. 2013;69(4):1031–6.
Article
PubMed
Google Scholar
Kaguelidou F, Turner MA, Choonara I, Jacqz-Aigrain E. Ciprofloxacin use in neonates: a systematic review of the literature. Pediatr Infect Dis J. 2011;30(2):e29–37.
Article
PubMed
Google Scholar
Adefurin A, Sammons H, Jacqz-Aigrain E, Choonara I. Ciprofloxacin safety in paediatrics: a systematic review. Arch Dis Child. 2011;96(9):874–80.
Article
PubMed
PubMed Central
Google Scholar
Castagnola E, Jacqz-Aigrain E, Kaguelidou F, Maragliano R, Stronati M, Rizzollo S, et al. Fluconazole use and safety in the nursery. Early Hum Dev. 2012;88 Suppl 2:S11–5.
Article
CAS
PubMed
Google Scholar
Egunsola O, Adefurin A, Fakis A, Jacqz-Aigrain E, Choonara I, Sammons H. Safety of fluconazole in paediatrics: a systematic review. Eur J Clin Pharmacol. 2013;69(6):1211–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kaguelidou F, Pandolfini C, Manzoni P, Choonara I, Bonati M, Jacqz-Aigrain E. European survey on the use of prophylactic fluconazole in neonatal intensive care units. Eur J Pediatr. 2012;171(3):439–45.
Article
CAS
PubMed
Google Scholar
Turner MA, Duncan JC, Shah U, Metsvaht T, Varendi H, Nellis G, et al. Risk assessment of neonatal excipient exposure: Lessons from food safety and other areas. Adv Drug Deliv Rev. 2014;73:89-101.
Nellis G, Lutsar I, Varendi H, Toompere K, Turner MA, Duncan J, et al. Comparison of two alternative study designs in assessment of medicines utilisation in neonates. BMC Med Res Methodol. 2014;14:89.
Article
PubMed
PubMed Central
Google Scholar
Sharland M. Manual of childhood infections. The Blue Book: Oxford University Press; 2011.
Book
Google Scholar
Paediatric Formulary Committee (ed). The BNF for Children. Pharmaceutical Press; London: BMJ Group; 2010.
Young T, Mangum B (eds.). NeoFax 2010. 23rd ed. Thomson Reuters; Montvale, NJ; 2010.
Turner MA, Duncan J, Shah U, Metsvaht T, Varendi H, Nellis G, et al. European study of neonatal exposure to excipients: an update. Int J Pharm. 2013;457(1):357–8.
Article
CAS
PubMed
Google Scholar
Oeser C, Lutsar I, Metsvaht T, Turner MA, Heath PT, Sharland M. Clinical trials in neonatal sepsis. J Antimicrob Chemother. 2013;68(12):2733-45.
Oeser C, Lutsar I, Metsvaht T, Turner MA, Heath PT, Sharland M. Clinical trials in neonatal sepsis. J Antimicrob Chemother. 2013;68(12):2733–45.
Article
CAS
PubMed
Google Scholar
Leroux S, Zhao W, Betremieux P, Pladys P, Saliba E, Jacqz-Aigrain E. Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey. Arch Dis Child. 2015;100(4):394-8.
Lestner JM, Versporten A, Doerholt K, Warris A, Roilides E, Sharland M, et al. Systemic antifungal prescribing in neonates and children: outcomes from the antibiotic resistance and prescribing in European children (ARPEC) study. Antimicrob Agents Chemother. 2015;59(2):782–9.
Article
CAS
PubMed
Google Scholar
de Hoog M, Mouton JW, van den Anker JN. New dosing strategies for antibacterial agents in the neonate. Semin Fetal Neonatal Med. 2005;10(2):185–94.
Article
PubMed
Google Scholar
Gouyon JB, Pechinot A, Safran C, Chretien P, Sandre D, Kazmierczak A. Pharmacokinetics of cefotaxime in preterm infants. Dev Pharmacol Ther. 1990;14(1):29–34.
CAS
PubMed
Google Scholar
van den Anker JN, Pokorna P, Kinzig-Schippers M, Martinkova J, de Groot R, Drusano GL, et al. Meropenem pharmacokinetics in the newborn. Antimicrob Agents Chemother. 2009;53(9):3871–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Padari H, Metsvaht T, Korgvee LT, Germovsek E, Ilmoja ML, Kipper K, et al. Short versus long infusion of meropenem in very-low-birth-weight neonates. Antimicrob Agents Chemother. 2012;56(9):4760–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tessin I, Thiringer K, Trollfors B, Brorson JE. Comparison of serum concentrations of ceftazidime and tobramycin in newborn infants. Eur J Pediatr. 1988;147(4):405–7.
Article
CAS
PubMed
Google Scholar
van den Anker JN, Schoemaker RC, Hop WC, van den Heijden BJ, Weber A, Sauer PJ, et al. Ceftazidime pharmacokinetics in preterm infants: effects of renal function and gestational age. Clin Pharmacol Ther. 1995;58(6):650–9.
Article
CAS
PubMed
Google Scholar
Pacifici GM. Pharmacokinetics of cephalosporins in the neonate: a review. Clinics (Sao Paulo). 2011;66(7):1267–74.
Article
Google Scholar
van den Anker JN, Schoemaker RC, van den Heijden BJ, Broerse HM, Neijens HJ, de Groot R. Once-daily versus twice-daily administration of ceftazidime in the preterm infant. Antimicrob Agents Chemother. 1995;39(9):2048–50.
Article
CAS
PubMed
PubMed Central
Google Scholar
Muller AE, DeJongh J, Bult Y, Goessens WH, Mouton JW, Danhof M, et al. Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks. Antimicrob Agents Chemother. 2007;51(10):3720–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
McCracken Jr GH, Threlkeld NE, Thomas ML. Pharmacokinetics of cefotaxime in newborn infants. Antimicrob Agents Chemother. 1982;21(4):683–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Metsvaht T, Oselin K, Ilmoja ML, Anier K, Lutsar I. Pharmacokinetics of penicillin g in very-low-birth-weight neonates. Antimicrob Agents Chemother. 2007;51(6):1995–2000.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rao SC, Srinivasjois R, Hagan R, Ahmed M. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev. 2011;11:CD005091.
PubMed
Google Scholar
Allegaert K, Scheers I, Cossey V, Anderson BJ. Covariates of amikacin clearance in neonates: the impact of postnatal age on predictability. Drug Metab Lett. 2008;2(4):286–9.
Article
CAS
PubMed
Google Scholar
Allegaert K, Anderson BJ, van den Anker JN, Vanhaesebrouck S, de Zegher F. Renal drug clearance in preterm neonates: relation to prenatal growth. Ther Drug Monit. 2007;29(3):284–91.
Article
CAS
PubMed
Google Scholar
Jacqz-Aigrain E, Zhao W, Sharland M, van den Anker JN. Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration. Semin Fetal Neonatal Med. 2013;18(1):28–34.
Article
PubMed
Google Scholar
Cantey JB, Wozniak PS, Sanchez PJ. Prospective surveillance of antibiotic use in the neonatal intensive care unit: results from the SCOUT study. Pediatr Infect Dis J. 2015;34(3):267-72.
Mtitimila EI, Cooke RW. Antibiotic regimens for suspected early neonatal sepsis. Cochrane Database Syst Rev. 2004;4:CD004495.
PubMed
Google Scholar
Metsvaht T, Ilmoja M-L, Parm Ü, Maipuu L, Merila M, Lutsar I. Comparison of ampicillin plus gentamicin vs penicillin plus gentamicin in empiric treatment of neonates at risk of early onset sepsis. Acta Paediatr. 2010;99(5):665–72.
CAS
PubMed
Google Scholar
Okike IO, Johnson AP, Henderson KL, Blackburn RM, Muller-Pebody B, Ladhani SN, et al. Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United Kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance. Clin Infect Dis. 2014;59(10):e150-7.
Ho NK, Low YP, See HF. Septic arthritis in the newborn–a 17 years’ clinical experience. Singapore Med J. 1989;30(4):356–8.
CAS
PubMed
Google Scholar
Webb R, Voss L, Roberts S, Hornung T, Rumball E, Lennon D. Infective endocarditis in New Zealand children 1994–2012. Pediatr Infect Dis J. 2014;33(5):437–42.
Article
PubMed
Google Scholar
Day MD, Gauvreau K, Shulman S, Newburger JW. Characteristics of children hospitalized with infective endocarditis. Circulation. 2009;119(6):865–70.
Article
PubMed
Google Scholar